Tysabri every eight weeks may cut PML risk
Tysabri every eight weeks may cut PML risk
Preliminary findings from an ongoing study of multiple sclerosis patients suggest the dosing interval for Tysabri can be as much as doubled from the label-recommended standard without sacrificing efficacy, and with potentially less risk of progressive multifocal leukoencephalopathy (PML) -- even among patients with more than average PML risk, researchers claim... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 2857 Views
-
Last post by NHE
-
- 0 Replies
- 717 Views
-
Last post by NHE
-
- 6 Replies
- 8735 Views
-
Last post by ElliotB
-
- 0 Replies
- 4392 Views
-
Last post by NHE
-
- 0 Replies
- 1641 Views
-
Last post by NHE
-
- 0 Replies
- 2103 Views
-
Last post by NHE
-
- 0 Replies
- 3722 Views
-
Last post by NHE
-
- 11 Replies
- 3685 Views
-
Last post by NHE
-
- 1 Replies
- 1355 Views
-
Last post by NHE